<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>JY Consulting . Ltd.</title>
        <link>
        https://www.jysupport.com/en/</link>
        <description>SMO Support</description>
        <lastBuildDate>Mon, 01 Jun 2026 14:54:47 +1600</lastBuildDate>
        <docs>http://backend.userland.com/rss/</docs>
        <generator>XOOPS</generator>
        <category>News</category>
        <managingEditor>admin at nc dot com dot tw</managingEditor>
        <webMaster>admin at nc dot com dot tw</webMaster>
        <language>en</language>
                    <image>
                <title>JY Consulting . Ltd.</title>
                <url>https://www.jysupport.com/en/images/logo.png</url>
                <link>
                https://www.jysupport.com/en/</link>
                <width>144</width>
                <height>48</height>
            </image>
                            <item>
                <title>Phases of Clinical Trials Explained: The Long Journey from the Lab to Your Medicine Cabinet</title>
                <link>
                https://www.jysupport.com/en/modules/news/article.php?storyid=7</link>
                <description>&lt;p&gt;Have you ever stopped to wonder what a drug goes through before it ends up on a pharmacy shelf? From the moment a new compound is synthesized to the day it receives regulatory approval, the process typically spans more than a decade and costs billions of dollars. At the heart of that journey is &lt;strong&gt;clinical trial&lt;/strong&gt; research — a rigorous, highly regulated series of studies designed to prove that a treatment is both safe and effective. Understanding the &lt;strong class=&quot;orange&quot;&gt;phases of clinical trials&lt;/strong&gt; isn&apos;t just essential knowledge for pharmaceutical professionals and healthcare workers. For patients and the general public, it matters too — because one day, you or someone you love might face the very real question of whether to participate in a &lt;strong&gt;clinical trial&lt;/strong&gt;.&lt;/p&gt;</description>
                <pubDate>Fri, 29 May 2026 15:50:00 +1600</pubDate>
                <guid>https://www.jysupport.com/en/modules/news/article.php?storyid=7</guid>
            </item>
                    <item>
                <title>臨床試驗概覽介紹</title>
                <link>
                https://www.jysupport.com/en/modules/news/article.php?storyid=1</link>
                <description>&lt;p&gt;臨床試驗是一種以人類為受試者所進行的前瞻性生物醫學或行為研究，旨在回答與生物醫學或行為干預措施相關的特定問題，包括新的治療方式(如新型疫苗、藥物、飲食選擇、膳食補充劑和醫療器械)以及需要進一步研究和比較的已知干預措施。臨床試驗可產生有關劑量、安全性和療效的數據。只有在獲得所尋求療程批准的國家/地區的衛生主管機構/倫理委員會批准後，才能進行臨床試驗。這些機構負責審查試驗的風險/效益比率——他們的批准並不意味著該療程&quot;安全&quot;或有效，只是允許進行該試驗。&lt;/p&gt;</description>
                <pubDate>Thu, 30 May 2024 09:20:00 +1600</pubDate>
                <guid>https://www.jysupport.com/en/modules/news/article.php?storyid=1</guid>
            </item>
                    <item>
                <title>臨床試驗準備階段</title>
                <link>
                https://www.jysupport.com/en/modules/news/article.php?storyid=3</link>
                <description>&lt;p&gt;在臨床試驗準備階段,提供專業且資深的試驗人員支援確實可以為整個試驗過程帶來許多助益。&lt;/p&gt;</description>
                <pubDate>Wed, 29 May 2024 08:50:00 +1600</pubDate>
                <guid>https://www.jysupport.com/en/modules/news/article.php?storyid=3</guid>
            </item>
                    <item>
                <title>臨床試驗執行階段</title>
                <link>
                https://www.jysupport.com/en/modules/news/article.php?storyid=4</link>
                <description>&lt;p&gt;在臨床試驗執行階段,專業試驗人員的參與扮演著關鍵角色,確保試驗能夠順利、高品質地執行。&lt;/p&gt;</description>
                <pubDate>Tue, 28 May 2024 08:10:00 +1600</pubDate>
                <guid>https://www.jysupport.com/en/modules/news/article.php?storyid=4</guid>
            </item>
                    <item>
                <title>臨床試驗患者和公眾參與</title>
                <link>
                https://www.jysupport.com/en/modules/news/article.php?storyid=2</link>
                <description>&lt;p&gt;除了作為臨床試驗的參與者，公眾成員還可以積極與研究人員合作，參與設計和執行臨床研究。這被稱為患者和公眾參與(PPI)。公眾參與涉及患者、照護者、患病經歷者和研究人員之間的工作夥伴關係，以塑造和影響研究的內容和方式。PPI可以提高研究的質量，使之更加相關和易於獲取。患有疾病的現任或曾經患病的人，可以提供與專業人士不同的觀點，以補充他們的知識。憑藉他們的個人經驗，他們可以確定相關且重要的研究主題，針對他們所屬的特定社區的需求。公眾參與者還可以確保以淺白易懂的語言呈現研究內容，使更廣泛的社會和特定相關群體都能理解。&lt;/p&gt;</description>
                <pubDate>Sat, 11 May 2024 09:30:00 +1600</pubDate>
                <guid>https://www.jysupport.com/en/modules/news/article.php?storyid=2</guid>
            </item>
                    <item>
                <title>臨床試驗結束階段</title>
                <link>
                https://www.jysupport.com/en/modules/news/article.php?storyid=5</link>
                <description>&lt;p&gt;&lt;span style=&quot;font-size: x-large;&quot;&gt;在臨床試驗結束階段,專業試驗人員的協助可確保數據收集與試驗關案工作得以順利完成。&lt;/span&gt;&lt;/p&gt;</description>
                <pubDate>Tue, 07 May 2024 09:10:00 +1600</pubDate>
                <guid>https://www.jysupport.com/en/modules/news/article.php?storyid=5</guid>
            </item>
                    <item>
                <title>Site Management Organization(SMO)</title>
                <link>
                https://www.jysupport.com/en/modules/news/article.php?storyid=6</link>
                <description>&lt;p&gt;&lt;strong&gt;Site Management Organization(SMO)&lt;/strong&gt; is an organization that provides clinical trial-related services to contract research organizations (CROs), pharmaceutical companies, biotechnology companies, medical device companies, or clinical trial sites. Trial sites are typically hospitals or similar healthcare facilities that have the necessary infrastructure and personnel to meet the requirements of the clinical trial protocol.&lt;/p&gt;</description>
                <pubDate>Mon, 07 Jun 2021 09:10:00 +1600</pubDate>
                <guid>https://www.jysupport.com/en/modules/news/article.php?storyid=6</guid>
            </item>
            </channel>
</rss>
